May 2019

aedifica

Co-Lead Manager

€ 418 million

Rights Issue

Aedifica

Co-Lead Manager

Kempen acted as Co-Lead Manager in the successful €418 million rights issue of Aedifica

Transaction highlights

Offering of 6,147,142 new shares (c. 30% of pre-deal outstanding share capital)
Subscription price of €68.00 per share, 10.8% discount to TERP based on Euronext Brussels closing price on 23 April 2019 adjusted for pro rata dividend
Kempen acted as Co-Lead Manager in this transaction

Company description

Aedifica is a leading Belgian listed company investing in healthcare real estate in Germany, The Netherlands, and Belgium, particularly in terms of senior housing.
In selecting assets, the company aims to create a portfolio which balances a recurring revenue oriented strategy with a potential for capital gains.
Aedifica is currently in the process of orienting its asset base towards becoming a pure play healthcare real estate investor in Europe